Denis Chem Lab Ltd.
| BSE: 537536 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE051G01012 |
| BSE 00:00 | 18 Jun | 52.00 |
-0.65 (-1.23%) |
OPEN
54.00 |
HIGH
54.00 |
LOW
51.00 |
| NSE 05:30 | 01 Jan | Denis Chem Lab Ltd |
| OPEN | 54.00 |
| PREVIOUS CLOSE | 52.65 |
| VOLUME | 7349 |
| 52-Week high | 74.00 |
| 52-Week low | 31.15 |
| P/E | 31.90 |
| Mkt Cap.(Rs cr) | 72 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Denis Chem Lab Ltd. (DENISCHEMLAB) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Sun Pharma.Inds. | 668.40 | 3.70 | 0.56 | 3211.14 |
| Dr Reddy's Labs | 5284.60 | -3.70 | -0.07 | 2937.70 |
| Cipla | 960.25 | 9.35 | 0.98 | 2318.17 |
| Aurobindo Pharma | 952.30 | -10.60 | -1.10 | 1872.74 |
| Cadila Health. | 620.20 | -0.05 | -0.01 | 1412.90 |
| Divi's Lab. | 4192.80 | -108.30 | -2.52 | 1372.71 |
| Glenmark Pharma. | 640.75 | 1.50 | 0.23 | 1354.55 |
| Alkem Lab | 3137.20 | -30.10 | -0.95 | 1264.42 |
| Alembic Pharma | 975.50 | -15.25 | -1.54 | 1175.39 |
| Torrent Pharma. | 2898.35 | -54.95 | -1.86 | 938.51 |
| Gland Pharma | 3076.95 | -24.60 | -0.79 | 772.86 |
| Lupin | 1157.15 | -5.50 | -0.47 | 727.55 |
| Ajanta Pharma | 1949.50 | -20.25 | -1.03 | 675.64 |
| Ipca Labs. | 1990.85 | -37.70 | -1.86 | 652.46 |
| Abbott India | 16507.55 | -21.40 | -0.13 | 592.93 |
| Fortis Health. | 232.60 | -1.35 | -0.58 | 513.33 |
| Pfizer | 5404.45 | -0.75 | -0.01 | 509.13 |
| Sanofi India | 7628.65 | -122.80 | -1.58 | 477.60 |
| Natco Pharma | 1095.15 | 14.00 | 1.29 | 474.50 |
| Apollo Hospitals | 3221.90 | -18.45 | -0.57 | 470.30 |
Quick Links for Denis Chem Lab:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
